This LSPN panel brings together experts from Troutman Pepper Locke, Sauvegarder Investment Management, Beam Therapeutics, ...

The team brings decades of litigation experience, with practices covering sectors from AI and life sciences to software and ...

The pharma manufacturer defeats an Italian hemp firm’s EU trademark bid | Claimed name could be confused for its blockbuster ...

23 January 2025 Teva insisted panel’s narrow interpretation of ‘claims the drug’ will have a seismic effect on the Orange ...

29 October 2024 A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an ...

Texas pharmacy accused of mass-producing unapproved tirzepatide drugs | Lilly claimed pharmacy falsely marketed copycat ...

Novartis moves to block cancer drug generic in US ...

Jennifer Che of Eagle IP explores key IP challenges in China and offers practical strategies to address them, covering topics ...

Court delivers default judgment dismissing EOFlow’s patent revocation claim | Dispute escalates following EOFlow’s refusal to ...

Design and colour combination deemed ‘too common’ in the pharma sector for protection | Court says trademarks must be ...

US State Department has said it is engaging with Chinese officials to resolve situation | Federal employee failed to disclose ...

Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | ...